GST rate concessions on Coivd-19 relief measures
Extension of existing concessional GST rates (currently valid till 30th September 2021) on Amphotericin B, Remdesivir, Tocilizumab, Anti-coagulants like Heparin drugs, up to 31st December 2021.
Reduction of GST rate to 5% on more Covid-19 treatment drugs, i.e Itolizumab, Posaconazole, Infliximab, Favipiravir, Casirivimab & Imdevimab, 2-Deoxy-D-Glucose, Bamlanivimab & Etesevimabup to 31st December 2021.